Clinical Trial Update: Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors

View source ↗

Summary

This clinical trials update describes an expanded access protocol for SL-28 in patients with advanced solid tumors and lists eligible conditions, indicating the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer
• Head and Neck Cancer
• Neuroblastoma
• Non-small Cell Lung Cancer
• Pancreatic Cancer
• Prostate Cancer with Bone Metastases

Drugs mentioned

• SL-28

Snippet

Sponsor: Second Life Therapeutics | Conditions: Neuroblastoma in Children, Neuroblastoma, Recurrent, Refractory | Status: AVAILABLE